Critics of the MediAsas plan, including prominent health economists, warn that the government may be steering Malaysia toward a dangerous, market-driven healthcare model similar to the United States. By relying on private insurance to solve systemic financing gaps, there is a significant risk that the country will see rising health expenditures while failing to achieve universal, equitable coverage. The concern is that focusing on private insurance products, even those branded as 'affordable,' does not address the root causes of medical inflation, such as the rising cost of services and hospital utilization.
There is also skepticism regarding the long-term viability of the RM65 premium. Critics point out that as claims inevitably rise, private insurers may face pressure to increase these premiums, potentially repeating the cycle of exclusion that the program was meant to solve. Because the government is not providing direct subsidies for premiums or claims, the burden remains entirely on the individual. This leaves low-to-middle-income households vulnerable to future price adjustments that could once again make their coverage unaffordable.
Furthermore, some experts argue that the government's energy would be better spent strengthening the public healthcare system rather than facilitating the expansion of private insurance. By prioritizing a private-sector solution, there is a fear that the focus on 'value-based care' and cost-containment will prioritize profit margins over patient outcomes. The reliance on private operators to deliver this 'lifeline' may ultimately create a two-tier system where quality care is increasingly tied to one's ability to pay, rather than the principle of universal health access.